Correlation Between Blueprint Medicines and AnaptysBio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and AnaptysBio, you can compare the effects of market volatilities on Blueprint Medicines and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and AnaptysBio.

Diversification Opportunities for Blueprint Medicines and AnaptysBio

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between Blueprint and AnaptysBio is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and AnaptysBio go up and down completely randomly.

Pair Corralation between Blueprint Medicines and AnaptysBio

Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.42 times more return on investment than AnaptysBio. However, Blueprint Medicines Corp is 2.39 times less risky than AnaptysBio. It trades about 0.22 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.29 per unit of risk. If you would invest  8,440  in Blueprint Medicines Corp on August 24, 2024 and sell it today you would earn a total of  1,317  from holding Blueprint Medicines Corp or generate 15.6% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.65%
ValuesDaily Returns

Blueprint Medicines Corp  vs.  AnaptysBio

 Performance 
       Timeline  
Blueprint Medicines Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Blueprint Medicines Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound primary indicators, Blueprint Medicines is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Blueprint Medicines and AnaptysBio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Blueprint Medicines and AnaptysBio

The main advantage of trading using opposite Blueprint Medicines and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.
The idea behind Blueprint Medicines Corp and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated